Cargando…
A Designed α‐GalCer Analog Promotes Considerable Th1 Cytokine Response by Activating the CD1d‐iNKT Axis and CD11b‐Positive Monocytes/Macrophages
Selective helper T cell 1 (Th1) priming agonists are a promising area of investigation for immunotherapeutic treatment of various diseases. α‐galactosylceramide (α‐GalCer, KRN7000), a well‐studied Th1‐polarizer, simultaneously induces helper T cell 2 (Th2)‐type responses, which is a major drawback f...
Autores principales: | Ma, Juan, He, Peng, Zhao, Chuanfang, Ren, Quanzhong, Dong, Zheng, Qiu, Jiahuang, Jing, Yang, Liu, Sijin, Du, Yuguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375225/ https://www.ncbi.nlm.nih.gov/pubmed/32714765 http://dx.doi.org/10.1002/advs.202000609 |
Ejemplares similares
-
α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials
por: Zhang, Yingting, et al.
Publicado: (2019) -
Galactosylsphingamides: new α-GalCer analogues to probe the F’-pocket of CD1d
por: Guillaume, Joren, et al.
Publicado: (2017) -
Synthesis of a 2''-Deoxy-β-GalCer
por: Thakur, Meena S., et al.
Publicado: (2014) -
Modulation of NKT cells and Th1/Th2 imbalance after α-GalCer treatment in progressive load-trained rats
por: Ru, Wang, et al.
Publicado: (2009) -
A Multifactorial Mechanism in the Superior Antimalarial Activity of α-C-GalCer
por: Schmieg, John, et al.
Publicado: (2010)